Diabetes Self-Management Articles

These articles cover a wide range of subjects, from the most basic aspects of diabetes care to the nitty-gritty specifics.

Links not loading properly?

Some of our pages use Portable Document Format (PDF) files, which require Adobe Acrobat Reader. To download Acrobat Reader for free, visit www.adobe.com.

Sign up for our weekly e-mail newsletter and receive a FREE GIFT! Enter your e-mail below.

Learn more

Learn more about diabetes

Links to help you learn more about diabetes.

Ask a diabetes expert
Other diabetes resources
Browse article topics


Insulin Analog

Also in 2000, the FDA granted marketing approval for a long-acting insulin analog called insulin glargine (brand name Lantus), manufactured by Aventis Pharmaceuticals. In insulin glargine, two molecules of the amino acid arginine are added to one end of the B chain, and one molecule of glycine is substituted for asparagine at position A21. The previously available intermediate-acting insulin NPH is absorbed somewhat unevenly into the bloodstream and has a pronounced “peak” in its activity level. Insulin glargine, however, because of its altered structure, is released very slowly and evenly into the bloodstream. Since its effects last nearly 24 hours with little variability and no peak action level, insulin glargine could be an ideal basal, or long-acting, insulin. A number of studies have compared the use of insulin glargine with that of the widely used NPH. They showed that regimens using insulin glargine offered blood glucose control that was at least as good as and sometimes better than that seen with NPH, and produced fewer episodes of hypoglycemia and less weight gain.

Researchers and manufacturers continue to look for more effective basal insulin analogs. In 2005, a new basal insulin analog called insulin detemir, marketed by Novo Nordisk as Levemir, was approved by the FDA. In insulin detemir, the amino acid threonine is removed from position B30 and a fatty acid is chemically linked to the amino acid lysine at position B29. These changes cause insulin detemir to bind readily to albumin, a protein found in the body, and dissociate slowly, thus prolonging its effect. Insulin detemir lasts an average of 14 hours.

Page    1    2    Show All    



More articles on Diabetes Definitions



Statements and opinions expressed on this Web site are those of the authors and not necessarily those of the publishers or advertisers. The information provided on this Web site should not be construed as medical instruction. Consult appropriate health-care professionals before taking action based on this information.



The Costs of Innovation
As readers of this blog surely know, living with diabetes in the United States can be expensive... Blog

Everything You Ever Wanted to Know About Injecting Insulin…
Just take your shot. What could be easier, right? Well, you’d be surprised how many errors... Article

Lobegon Participants Continue to Dwindle
Are you keeping warm out there? Our high on Sunday was minus 2 degrees. We also had about 1... Blog

How frequently should I check my blood glucose while I'm pregnant? Get tip

Carbohydrate Restriction: An Option for Diabetes Management
Some people find that decreasing the amount of carbohydrate they eat can help with blood glucose control. Here’s what to know about this approach.

Insulin Patch Pumps: A New Tool for Type 2
Patch pumps are simpler to operate than traditional insulin pumps and may be a good option for some people with Type 2 diabetes who need insulin.

How Much Do You Know About Vitamins?
Learn what these micronutrients can and can’t do for you.

Complete table of contents
Subscription questions